首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1863685篇
  免费   127047篇
  国内免费   2778篇
耳鼻咽喉   25993篇
儿科学   62267篇
妇产科学   48739篇
基础医学   279456篇
口腔科学   48008篇
临床医学   164504篇
内科学   366931篇
皮肤病学   42057篇
神经病学   142669篇
特种医学   71520篇
外国民族医学   760篇
外科学   278023篇
综合类   33925篇
现状与发展   2篇
一般理论   522篇
预防医学   142593篇
眼科学   41043篇
药学   139080篇
  3篇
中国医学   3788篇
肿瘤学   101627篇
  2019年   15275篇
  2018年   23235篇
  2017年   16928篇
  2016年   18476篇
  2015年   20743篇
  2014年   27303篇
  2013年   41523篇
  2012年   60650篇
  2011年   64281篇
  2010年   36818篇
  2009年   33362篇
  2008年   59589篇
  2007年   64282篇
  2006年   63111篇
  2005年   61408篇
  2004年   59481篇
  2003年   57009篇
  2002年   55531篇
  2001年   83085篇
  2000年   85846篇
  1999年   72780篇
  1998年   19688篇
  1997年   17590篇
  1996年   17952篇
  1995年   17015篇
  1994年   15939篇
  1993年   14887篇
  1992年   57076篇
  1991年   56993篇
  1990年   55680篇
  1989年   53338篇
  1988年   49225篇
  1987年   48344篇
  1986年   45099篇
  1985年   43230篇
  1984年   32261篇
  1983年   27252篇
  1982年   15519篇
  1981年   14075篇
  1979年   29225篇
  1978年   20473篇
  1977年   17169篇
  1976年   16528篇
  1975年   18556篇
  1974年   21426篇
  1973年   20626篇
  1972年   19029篇
  1971年   17604篇
  1970年   16540篇
  1969年   15239篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
32.

Background

We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.

Methods

In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).

Results

After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).

Conclusions

This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy.  相似文献   
33.
We report the case of a littoral‐cell angioma of the spleen, a recently described benign vascular tumour, whose imaging and pathological characteristics have been discussed only by a few authors. The diagnosis was made after elective splenectomy. The CT images, scintigraphy and histological specimens are presented, and differential diagnoses discussed.  相似文献   
34.
35.
Bernard–Soulier syndrome (BSS) is a rare autosomal recessively inherited bleeding disorder. Pregnancy in patients with BSS is characterized by ante‐, intra‐, or postpartum haemorrhage, which may be delayed and severe. There is no consensus in the management of BSS in pregnancy and so far only 16 pregnancies in nine patients have been described. We report a further three pregnancies in two women with the syndrome. We also outline our management of pregnant patients with BSS.  相似文献   
36.
Conclusion  Several quality-control measures take place before (patient and camera preparation) and during SPECT acquisition to achieve high-quality images. Not uncommonly, technologists and physicians are left with suboptimal images that have to be addressed to reach the “right answer” for patient diagnosis and hence management. In many cases patients may be reimaged, especially if the problem is detected early, but in other cases either the patient has left the nuclear laboratory or there is an inevitable problem that, even with reimaging, will not be resolved. In these situations the technologist and physician have to seek the available techniques to obtain the best images possible. These resources are discussed in this issue as an aid in quality control to obtain the best possible images.  相似文献   
37.
38.
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号